| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −3.1× | −1.8× | |
| Price / Book | 0.9× | 2.1× | |
| Price / Sales | 28.2× | 4.0× | |
| Price / Free cash flow | −3.1× | −1.6× | |
| EV / EBITDA | −0.9× | −1.2× | |
| Earnings yield | −31.8% | −14.0% | |
| Free cash flow yield | −32.4% | −9.5% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,269.63 | −2.84% | $1.2T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.92 | −1.38% | $635.34B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $286.50 | +0.46% | $506.28B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $417.33 | −1.80% | $374.59B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $145.25 | −1.35% | $358.36B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.68 | −3.58% | $271.52B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $171.42 | −0.67% | $265.86B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $670.18 | −0.94% | $247.8B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $440.23 | −1.58% | $238B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $157.11 | −0.05% | $194.81B | 22.9× | 37.5% | +26.7% |
